Related Experiment Videos
Keyhole-limpet haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma
Urological Research
|January 1, 1983
Abstract:
The antigenicity of transitional cell carcinoma of the bladder has stimulated the search for effective immunotherapeutic agents in the treatment of this disease. Non-specific immunotherapy with local (intravesical/intralesional) and systemic Keyhole Limpet Haemocyanin (KLH) in a FANFT induced murine bladder tumor model was studied. Results showed no difference between control or treated groups in either tumor growth or animal survival.